Cure My Disease

Don't miss your cure!

 Log in / Sign up

New monthly shot could help people with obesity shed pounds

NCT ID NCT07595549

Disease control Sponsor: Pfizer Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 04, 2026 · Updated 7 times

Summary

This study tests a once-monthly injection called berobenatide to help adults with overweight or obesity lose weight. About 954 participants will receive either the drug or a placebo for 20 months. The goal is to see if the drug is safe and effective for weight loss, including in people with type 2 diabetes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 954 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

Jun 2028

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged ≥18 years. * BMI of: ≥30 kg/m2 or ≥27.0 kg/m2 to \<30.0 kg/m2 and must have at least 1 of the following weight-related co-morbidities: hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease, or T2D. Exclusion Criteria: * Have a self-reported body weight change greater than 5% within 90 days prior to Screening. * Diagnosis of type 1 diabetes or any other form of diabetes other than T2D. * History of acute or chronic pancreatitis. * Personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN-2).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Obesity are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Body Weight diabetes mellitus endocrine system disorder glucose metabolism disease metabolic disease Nutritional and Metabolic Diseases nutritional disorder Obesity obesity disorder overnutrition Overweight Pathological Conditions, Signs and Symptoms Signs and Symptoms type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Obesity Overweight Overweight and/or obesity

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    50 sites in 5 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Aa Mrc Llc

    RECRUITING

    Flint, Michigan, 48504, United States

  • Accellacare - Wilmington

    RECRUITING

    Wilmington, North Carolina, 28401, United States

  • Albuquerque Clinical Trials, Inc.

    RECRUITING

    Albuquerque, New Mexico, 87102, United States

  • Ascension Saint Agnes Heart Care

    NOT_YET_RECRUITING

    Baltimore, Maryland, 21229, United States

  • CEPIC - Centro Paulista de Investigação Clínica

    NOT_YET_RECRUITING

    São Paulo, 04266-010, Brazil

  • Canadian Phase Onward Inc.

    RECRUITING

    Toronto, Ontario, M3J 0K2, Canada

  • Cedar Crosse Research Center

    RECRUITING

    Chicago, Illinois, 60607, United States

  • Center for Diabetes, Obesity and Metabolism Inc

    RECRUITING

    Pembroke Pines, Florida, 33024, United States

  • Clinical Trials Research

    RECRUITING

    Sacramento, California, 95821, United States

  • Diablo Clinical Research, Inc.

    RECRUITING

    Walnut Creek, California, 94598, United States

  • Endeavor Health - Family Medicine Administration

    RECRUITING

    Evanston, Illinois, 60201, United States

  • Endeavor Health- Endocrinology Research

    RECRUITING

    Skokie, Illinois, 60077, United States

  • Fukuwa Clinic

    RECRUITING

    Chuo-ku, Tokyo, 104-0031, Japan

  • Fundação Faculdade Regional de Medicina de São José do Rio Preto

    NOT_YET_RECRUITING

    São José do Rio Preto, São Paulo, 15090-000, Brazil

  • GA Research Associates Ltd.

    RECRUITING

    Moncton, New Brunswick, E1G 1A7, Canada

  • Gachon University Gil Medical Center

    NOT_YET_RECRUITING

    Incheon, Incheon-gwangyeoksi, 21565, South Korea

  • Headlands Research California, LLC

    RECRUITING

    Escondido, California, 92025, United States

  • ImmuniMet, LLC

    RECRUITING

    Modesto, California, 95350, United States

  • Jeffrey Coleman, OD

    RECRUITING

    Wilmington, North Carolina, 28401, United States

  • Konyang University Hospital

    NOT_YET_RECRUITING

    Daejeon, Daejeon, 35365, South Korea

  • MediSphere Medical Research Center, LLC

    RECRUITING

    Evansville, Indiana, 47714, United States

  • Medical Corporation Heishinkai OCROM Clinic

    RECRUITING

    Suita, Osaka, 565-0853, Japan

  • Medical Corporation Heishinkai ToCROM Clinic

    RECRUITING

    Shinjuku-ku, Tokyo, 160-0008, Japan

  • Medication Management LLC

    RECRUITING

    Greensboro, North Carolina, 27405, United States

  • Midwest Eye Center

    RECRUITING

    Cincinnati, Ohio, 45202, United States

  • Monroe Biomedical Research

    RECRUITING

    Louisville, Kentucky, 40213, United States

  • Nature Coast Clinical Research

    RECRUITING

    Crystal River, Florida, 34429, United States

  • Northwestern University

    NOT_YET_RECRUITING

    Chicago, Illinois, 60611, United States

  • Ocean West Research Clinic

    RECRUITING

    Surrey, British Columbia, V3Z2N6, Canada

  • PlanIt Research, LLC

    RECRUITING

    Houston, Texas, 77079, United States

  • PlanIt Research, LLC (Monitoring Room)

    RECRUITING

    Houston, Texas, 77079, United States

  • Pusan National University Yangsan Hospital

    NOT_YET_RECRUITING

    Yangsan, Gyeongsangnam-do, 50612, South Korea

  • Rochester Clinical Research, LLC

    RECRUITING

    Rochester, New York, 14609, United States

  • San Fernando Valley Health Institute

    RECRUITING

    Canoga Park, California, 91304, United States

  • Saraiva & Berlinger Ltda EPP Instituto de Pesquisa Clínica de Campinas

    NOT_YET_RECRUITING

    Campinas, São Paulo, 13060-080, Brazil

  • South Broward Research

    RECRUITING

    Miramar, Florida, 33027, United States

  • Southern California Retina Specialists

    RECRUITING

    West Hills, California, 91307, United States

  • Suncoast Clinical Research, Inc.

    RECRUITING

    New Port Richey, Florida, 34652, United States

  • The Wharton Medical Clinic Clinical Trials Inc

    RECRUITING

    Hamilton, Ontario, L8L 5G8, Canada

  • Tokyo Center Clinic

    RECRUITING

    Chuo-ku, Tokyo, 103-0027, Japan

  • Tokyo-Eki Center-Building Clinic

    RECRUITING

    Chuo-ku, Tokyo, 103-0027, Japan

  • University Clinical Investigators, Inc.

    RECRUITING

    Tustin, California, 92780, United States

  • University Of Nebraska Medical Center

    RECRUITING

    Omaha, Nebraska, 68198, United States

  • VIP Trials

    RECRUITING

    San Antonio, Texas, 78230, United States

  • Velocity Clinical Research, Mt. Auburn

    RECRUITING

    Cincinnati, Ohio, 45219, United States

  • Weill Cornell Medicine - Comprehensive Weight Control Center

    RECRUITING

    New York, New York, 10021, United States

  • West Coast Eye Institute

    RECRUITING

    Lecanto, Florida, 34461, United States

  • West Coast Medical Associates

    RECRUITING

    New Port Richey, Florida, 34652, United States

  • Winterberry Research Inc.

    RECRUITING

    Hamilton, Ontario, L8J 0B6, Canada

  • York Clinical Research, LLC

    RECRUITING

    Norfolk, Virginia, 23504, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.